Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Procarbazine, Radiation therapy, Temozolomide, and Oncology.
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539
Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Phase III study of radiation therapy (RT) with or without procarbazine, CCNU, and vincristine (PCV) in low-grade glioma: RTOG 9802 with Alliance, ECOG, and SWOG.